Luca Cantarini

#Siena #University; #Rheumatology; #Rheumatologist; #RareDiseases; #Uveitis; #Autoinflammatory; #Behcet's; #Spondyloarthritis; Biologics; #Autoimmunity

[Rosaria (Sara) Talarico @SaraTalarico2]

Partecipa anche tu all’evento, iscrivendoti a questo link
👇🏻
https://t.co/mof2AOryUb @DianaMarinello @DTaruscio @GiuseppeLopalc2 @RMD_clinic @cantariniluca1

[Ophthalmology Ther @Ophthal_Therapy]

Role of Adalimumab Biosimilar in the Treatment of Non-Anterior Uveitis Associated with Behçet’s Syndrome: https://t.co/TuQ59EzcYk

[Luca Cantarini @cantariniluca1]

https://t.co/4Gt5VIFZUM

[Luca Cantarini @cantariniluca1]

7th International AIDA Meeting. 1st April | 1st June | 1st September | 3rd November 2021.
1 April 2021. Adult Onset Still Disease and Schnitzler’s syndrome

Free Registration:
https://t.co/vLbMF2JZNI

CONFERENCE LANGUAGE
English

#RheumTwitter

[Luca Cantarini @cantariniluca1]

Effectiveness of TNF-α blockade in the treatment of refractory non-infectious scleritis: a multicentre study. - PubMed - NCBI https://t.co/bCLM1QqGrN

[GEAS SEMI @GEAS_SEMI]

🎥
Entrevista #12GEAS
#SEMItuit

IL 1 Inhibition in #autoinflammatroy diseases
Dr. Cantarini
Siena

[Luca Cantarini @cantariniluca1]

Systemic Steroid Sparing Effect of Intravitreal Dexamethasone Implant in Chronic Noninfectious Uveitic Macular Edema
https://t.co/7IGUTyMUK5

[Associazione UNITAS @AssUNITAS]

#creativityvillage2

MAI PIÙ #BEHCET
Sosteniamo la ricerca

4 GIUGNO-INTERA GIORNATA
Piazzale ENRICO DE NICOLA
SAVIANO (NA)
@simbaonlus

[Luca Cantarini @cantariniluca1]

IL-6 blockade in the management of non-infectious uveitis. - PubMed - NCBI https://t.co/5qhzzriO7f

[Luca Cantarini @cantariniluca1]

https://t.co/CWBqfImNTC

[Luca Cantarini @cantariniluca1]

I biomarcatori e l’osteoartrosi della mano https://t.co/v0YVqSHaSx

[Luca Cantarini @cantariniluca1]

Cytokine Signatures in Mucocutaneous and Ocular Behçet's Disease. - PubMed - NCBI https://t.co/T7NuTvJy8o

[Luca Cantarini @cantariniluca1]

The emerging role of IL-1 in the pathogenesis and treatment of inflammatory and degenerative eye diseases https://t.co/xXFmZTRyFu

[Luca Cantarini @cantariniluca1]

Interleukin (IL)-1 inhibition with anakinra and canakinumab in Behçet's disease-related uveitis.... https://t.co/eVE0I2r0eF

[Luca Cantarini @cantariniluca1]

Long-term safety of anti-TNF agents on the liver of patients with spondyloarthritis and hepatitis B viral infection https://t.co/IIA6A4xat1

[Luca Cantarini @cantariniluca1]

Efficacy and safety of adalimumab in Behçet's disease-related uveitis.....
https://t.co/pJBHUAym2M

[Luca Cantarini @cantariniluca1]

https://t.co/6h3HwuTixb

[Luca Cantarini @cantariniluca1]

Adalimumab effectiveness in Behçet's disease: short and long-term data.... https://t.co/Zg6Vh8YGbb

[Luca Cantarini @cantariniluca1]

Drug survival of adalimumab in patients with rheumatoid arthritis over 10 years in the real-world........ https://t.co/wZ7UHBOAgR